166
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Effect of the filler grade on the characteristics and the sublingual permeability of atropine sulfate fast disintegrating sublingual tablets

, , &
Pages 1617-1623 | Received 05 Feb 2019, Accepted 16 Jul 2019, Published online: 22 Aug 2019

References

  • Balali-Mood M, Saber H. Recent advances in the treatment of organophosphorus poisonings. Iran J Med Sci. 2012;37:74–91.
  • Bertolote JM, Butchart A, Besbellli N. The impact of pesticides on health: preventing intentional and unintentional deaths from pesticide poisoning: pesticides and health Geneva, Switzerland: World Health Organization; 2004. Available from: http://www.who.int/mental_health/prevention/suicide/en/PesticidesHealth2.pdf?ua=1
  • Vijayaraghavan R. Autoinjector device for rapid administration of life saving drugs in emergency. Defence Sci J. 2012;62:8.
  • Karakus A, Celik MM, Karcioglu M, et al. Cases of organophosphate poisoning treated with high-dose of atropine in an intensive care unit and the novel treatment approaches. Toxicol Ind Health. 2014;30:421–425.
  • Gunnell D, Fernando R, Hewagama M, et al. The impact of pesticide regulations on suicide in Sri Lanka. Int J Epidemiol. 2007;36:1235–1242.
  • Kanchan T, Menezes RG, Kumar TS, et al. Toxicoepidemiology of fatal poisonings in Southern India. J Forensic Leg Med. 2010;17:344–347.
  • Brown JC, Tuuri RE, Akhter S, et al. Lacerations and embedded needles caused by epinephrine autoinjector use in children. Ann Emerg Med. 2016;67:307–315.e8.
  • Aodah A, Bafail RS, Rawas-Qalaji M. Formulation and evaluation of fast-disintegrating sublingual tablets of atropine sulfate: the effect of tablet dimensions and drug load on tablet characteristics. AAPS PharmSciTech. 2017;18:1624–1633.
  • Aodah A, Rawas-Qalaji M. The effect of tablet dimension and weight on the influx of atropine sulfate from novel rapidly disintegrating sublingual tablets. Poster session presented at: American Association of Pharmaceutical Scientists Annual Meeting; 2014 Nov 2–6; San Diego, CA.
  • Teubl BJ, Absenger M, Frohlich E, et al. The oral cavity as a biological barrier system: design of an advanced buccal in vitro permeability model. Eur J Pharm Biopharm. 2013;84:386–393.
  • Meanwell NA. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety. Chem Res Toxicol. 2011;24:1420–1456.
  • Jivraj M, Martini LG, Thomson CM. An overview of the different excipients useful for the direct compression of tablets. Pharm Sci Technol Today. 2000;3:58–63.
  • Moolchandani V, Augsburger LL, Gupta A, et al. Characterization and selection of suitable grades of lactose as functional fillers for capsule filling: part 1. Drug Dev Ind Pharm. 2015;41:1452–1463.
  • Rawas-Qalaji MM, Estelle F, Simons R, et al. Fast-disintegrating sublingual tablets: effect of epinephrine load on tablet characteristics. AAPS PharmSciTech. 2006;7:E72–E78.
  • Rawas-Qalaji MM, Simons FE, Simons KJ. Fast-disintegrating sublingual epinephrine tablets: effect of tablet dimensions on tablet characteristics. Drug Dev Ind Pharm. 2007;33:523–530.
  • USP/NF. General chapters:  < 1174> powder flow. In U.S. Pharmacopeia National Formulary. 41st ed. Rockville (MD): Pharmacopeial Convention, Inc.; 2018. p. 7481–7485.
  • USP/NF. General chapters:  < 1217> tablet breaking force. In U.S. Pharmacopeia National Formulary. 41st ed. Rockville (MD): Pharmacopeial Convention, Inc.; 2018. p. 7635–7638.
  • USP/NF. General chapters:  < 1216> tablet friability. In U.S. Pharmacopeia National Formulary. 41st ed. Rockville (MD): Pharmacopeial Convention, Inc.; 2018. p. 7634–7635.
  • USP/NF. General chapters:  < 905> uniformity of dosage units. In U.S. Pharmacopeia National Formulary. 41st ed. Rockville (MD): Pharmacopeial Convention, Inc.; 2018. p. 6673–6677.
  • Rachid O, Rawas-Qalaji M, Simons FE, et al. Dissolution testing of sublingual tablets: a novel in vitro method. AAPS PharmSciTech. 2011;12:544–552.
  • USP/NF. USP monographs: atropine sulfate injection. U.S. Pharmacopeia National Formulary. 41st ed. Rockville (MD): Pharmacopeial Convention, Inc.; 2018. p. 406–407.
  • Rawas-Qalaji MM, Werdy S, Rachid O, et al. Sublingual diffusion of epinephrine microcrystals from rapidly disintegrating tablets for the potential first-aid treatment of anaphylaxis: in vitro and ex vivo study. AAPS PharmSciTech. 2015;16:1203–1212.
  • CEOLUS [Internet]. Asahi Kasei Corporation; 2018; [cited 2018 Oct 10]. Available from: https://www.ceolus.com/en/ceolus_outline.html
  • Brniak W, Jachowicz R, Krupa A, et al. Evaluation of co-processed excipients used for direct compression of orally disintegrating tablets (ODT) using novel disintegration apparatus. Pharm Dev Technol. 2013;18:464–474.
  • Lopez FL, Bowles A, Gul MO, et al. Effect of formulation variables on oral grittiness and preferences of multiparticulate formulations in adult volunteers. Eur J Pharm Sci. 2016;92:156–162.
  • Kucera SU, DiNunzio JC, Kaneko N, et al. Evaluation of Ceolus microcrystalline cellulose grades for the direct compression of enteric-coated pellets. Drug Dev Ind Pharm. 2012;38:341–350.
  • Horio T, Yasuda M, Matsusaka S. Effect of particle shape on powder flowability of microcrystalline cellulose as determined using the vibration shear tube method. Int J Pharm. 2014;473:572–578.
  • Dinunzio JC, Schilling SU, Coney AW, et al. Use of highly compressible Ceolus microcrystalline cellulose for improved dosage form properties containing a hydrophilic solid dispersion. Drug Dev Ind Pharm. 2012;38:180–189.
  • Thoorens G, Krier F, Leclercq B, et al. Microcrystalline cellulose, a direct compression binder in a quality by design environment – a review. Int J Pharm. 2014;473:64–72.
  • USP/NF. General chapters:  < 701> disintegration. In U.S. Pharmacopeia National Formulary. 41st ed. Rockville (MD): Pharmacopeia Convention, Inc.; 2018. p. 6455–6457.
  • USP/NF. General chapters:  < 711> dissolution. In U.S. Pharmacopeia National Formulary. 41st ed. Rockville (MD): Pharmacopeia Convention, Inc.; 2018. p. 6459–6469.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.